4//SEC Filing
FAHIM RAAFAT E F 4
Accession 0001455244-11-000004
CIK 0000072444other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 3:21 PM ET
Size
5.2 KB
Accession
0001455244-11-000004
Insider Transaction Report
Form 4
FAHIM RAAFAT E F
DirectorPresident, CEO and CFO
Transactions
- Sale
Common Stock
2011-01-05$5.65/sh−3,181$17,973→ 330,637.941 total
Footnotes (1)
- [F1]This disposition was made to fund the Reporting Person's tax obligation arising from the vesting of restricted stock.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001271999
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 3:21 PM ET
- Size
- 5.2 KB